Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity CRVS - Corvus Pharmaceuticals, Inc.
45.6 M
LAST VALUE
-35.49%
2 YEAR CAGR
-17.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR